Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2814084643;84644;84645 chr2:178561714;178561713;178561712chr2:179426441;179426440;179426439
N2AB2649979720;79721;79722 chr2:178561714;178561713;178561712chr2:179426441;179426440;179426439
N2A2557276939;76940;76941 chr2:178561714;178561713;178561712chr2:179426441;179426440;179426439
N2B1907557448;57449;57450 chr2:178561714;178561713;178561712chr2:179426441;179426440;179426439
Novex-11920057823;57824;57825 chr2:178561714;178561713;178561712chr2:179426441;179426440;179426439
Novex-21926758024;58025;58026 chr2:178561714;178561713;178561712chr2:179426441;179426440;179426439
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: Y
  • RefSeq wild type transcript codon: TAC
  • RefSeq wild type template codon: ATG
  • Domain: Fn3-92
  • Domain position: 86
  • Structural Position: 120
  • Q(SASA): 0.4943
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
Y/C None None 0.994 N 0.566 0.312 0.420939154896 gnomAD-4.0.0 1.20032E-06 None None None None N None 0 0 None 0 0 None 0 0 0 6.07533E-05 0
Y/H rs1703729439 None 0.007 N 0.355 0.121 0.214338557667 gnomAD-4.0.0 1.59848E-06 None None None None N None 0 0 None 0 0 None 0 0 2.87289E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
Y/A 0.3505 ambiguous 0.3198 benign -2.673 Highly Destabilizing 0.016 N 0.434 neutral None None None None N
Y/C 0.104 likely_benign 0.1116 benign -1.161 Destabilizing 0.994 D 0.566 neutral N 0.462704596 None None N
Y/D 0.4103 ambiguous 0.3742 ambiguous -1.935 Destabilizing 0.521 D 0.553 neutral N 0.474225486 None None N
Y/E 0.7386 likely_pathogenic 0.6895 pathogenic -1.802 Destabilizing 0.742 D 0.549 neutral None None None None N
Y/F 0.0774 likely_benign 0.0789 benign -1.047 Destabilizing 0.815 D 0.511 neutral N 0.419005241 None None N
Y/G 0.3568 ambiguous 0.3301 benign -3.027 Highly Destabilizing 0.373 N 0.499 neutral None None None None N
Y/H 0.1931 likely_benign 0.1785 benign -1.354 Destabilizing 0.007 N 0.355 neutral N 0.473971996 None None N
Y/I 0.4709 ambiguous 0.4517 ambiguous -1.546 Destabilizing 0.854 D 0.607 neutral None None None None N
Y/K 0.7641 likely_pathogenic 0.6931 pathogenic -1.384 Destabilizing 0.742 D 0.543 neutral None None None None N
Y/L 0.4914 ambiguous 0.4693 ambiguous -1.546 Destabilizing 0.742 D 0.505 neutral None None None None N
Y/M 0.6628 likely_pathogenic 0.6317 pathogenic -1.156 Destabilizing 0.984 D 0.593 neutral None None None None N
Y/N 0.2555 likely_benign 0.2259 benign -1.831 Destabilizing 0.007 N 0.425 neutral N 0.467224047 None None N
Y/P 0.3241 likely_benign 0.3125 benign -1.925 Destabilizing 0.953 D 0.595 neutral None None None None N
Y/Q 0.6339 likely_pathogenic 0.5785 pathogenic -1.756 Destabilizing 0.91 D 0.624 neutral None None None None N
Y/R 0.6133 likely_pathogenic 0.5483 ambiguous -0.928 Destabilizing 0.742 D 0.595 neutral None None None None N
Y/S 0.1725 likely_benign 0.1682 benign -2.341 Highly Destabilizing 0.309 N 0.505 neutral N 0.497831384 None None N
Y/T 0.4252 ambiguous 0.4015 ambiguous -2.109 Highly Destabilizing 0.742 D 0.553 neutral None None None None N
Y/V 0.3433 ambiguous 0.3364 benign -1.925 Destabilizing 0.742 D 0.502 neutral None None None None N
Y/W 0.3368 likely_benign 0.3208 benign -0.466 Destabilizing 0.996 D 0.567 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.